Our partner is a preclinical-stage, publicly traded biopharmaceutical company that is shaping the future of heart disease treatment driven by a bold mission: to discover, develop and deliver curative therapies that address the underlying drivers of disease. Founded by leading cariology researchers, they are developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Regeneration and Precision Medicine.

This critical quality hire held experience, knowledge, and leadership credibility to be effective across the company in multiple capacities. They ensured compliance with Quality standards and corporate-wide commitment to Quality principles. As part of the leadership team, they translated quality strategy into operational policies, processes, procedures, and training to meet global regulatory, medical/health, and legislative standards.